XML 32 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Cash flows from operating activities:    
Net income (loss) $ 739 $ (48,808)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Depreciation and amortization 2,424 1,967
Stock-based compensation expense 1,279 2,911
Inventory impairments and option contract abandonments 3,535 921
Deferred and other income tax (benefit) provision (36,065) 65
Provision for doubtful accounts 3 9
Excess tax benefit from equity-based compensation 4 1,557
Equity in loss (income) of unconsolidated joint ventures 106 (63)
Cash distributions of income from unconsolidated joint ventures   38
Loss on extinguishment of debt   1,967
Changes in operating assets and liabilities:    
Decrease in accounts receivable 333 5,092
Decrease in income tax receivable 1,742 1,719
Decrease (increase) in inventory 12,097 (47,566)
Decrease in other assets 1,485 663
Decrease in trade accounts payable (26,300) (21,108)
Decrease in other liabilities (32,448) (36,342)
Other changes (21) (65)
Net cash used in operating activities (71,087) (137,043)
Cash flows from investing activities:    
Capital expenditures (8,636) (2,405)
Investments in unconsolidated joint ventures (477) (1,106)
Increases in restricted cash (672) (32,819)
Decreases in restricted cash 489 1,395
Net cash used in investing activities (9,296) (34,935)
Cash flows from financing activities:    
Repayment of debt (1,522) (185,696)
Proceeds from issuance of new debt   246,387
Proceeds from issuance of cash secured loan   32,591
Debt issuance costs (97) (5,060)
Settlement of unconsolidated JV debt obligation (15,862)  
Common stock redeemed (11) (64)
Excess tax benefit from equity-based compensation (4) (1,557)
Net cash (used in) provided by financing activities (17,496) 86,601
Decrease in cash and cash equivalents (97,879) (85,377)
Cash and cash equivalents at beginning of period 370,403 537,121
Cash and cash equivalents at end of period $ 272,524 $ 451,744